Furthermore, MIRO1 degradation during mitophagy may be pathologically relevant as resistance to mitophagy and subsequent protection of MIRO1 degradation has been observed in patients with Parkinson’s disease (48). This evidence concerns the gene RHOT1 and Parkinson disease.